Unlock the cancer drug fund
It's hard to believe that people in the UK are struggling to access treatment they so vitally need. But for many it's a reality.
How you can help
A consultation has been launched to look at how the £200 million should be spent. This is your opportunity to unlock the cancer drug fund.
Add your name to our pledge and urge the government to make sure access to cancer drugs is fair for everyone.
Why are people with rarer cancers losing out?
The National Institute of Clinical Excellence (NICE) has to approve drugs before they become available through the NHS. Often NICE can't approve drugs for rarer cancers because:
a smaller number of people need them, which makes them more expensive
there are not always enough people to take part in trials to get them approved
they have to make sure NHS money is spent effectively, balancing the benefits of a drug against cost.
Everyone should get the drugs they need regardless of what type of cancer they have or where they live. And it’s not just us who think this. Our survey found that 90% of the public support people with rarer cancers having the same access to cancer drugs as people with common cancers, even if they're more expensive.